ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy

Li, Huijun; Xu, Jialin; Zhang, Yanan; Hong, Lei; He, Zhijian; Zeng, Zhiheng*; Zhang, Li*广东药学院; 浙江大学; 1
Human Cell2022-11DOI: 10.1007/s13577-022-00758-6
4被引10阅读
引用收藏
分享

摘要

Astragaloside IV (AS-IV), as one of the main active components of Astragalus membranaceus, has been reported to have cardiovascular protective effects. However, the role and molecular mechanism of AS-IV in vascular senescence have not been clearly stated. The in vitro aging model was constructed using bleomycin (BLM) in vascular smooth muscle cells (VSMCs). Cell senescence were assessed through Western blotting analysis of aging markers, flow cytometry, and the beta-galactosidase (SA-beta-Gal) kit. Mitophagy was determined through transmission electron microscopy, TMRM staining, and Western blotting analysis of p62. A model of aging blood vessels was induced by d-gal. The vascular wall thickness of mice was also evaluated by H&E staining. Our data proved that AS-IV plays an anti-senescent role in vitro and in vivo. Results showed that AS-IV effectively improved mitochondrial injury, raised MMP, and mediated mitophagy in BLM-induced senescent VSMCs and d-gal induced aging mice. Parkin expression strengthened AS-IV's anti-senescent function. In conclusions, AS-IV attenuated BLM-induced VSMC senescence via Parkin to regulate mitophagy. Therefore, AS-IV-mediated Parkin might be a latent therapeutic agent and target for VSMC senescence.

学科与关键词

关键词
Astragaloside IVSenescenceVascular smooth muscle cellsParkinMitophagy
相关
加载中…
  • The BCL2/BAX/ROS pathway is involved in the inhibitory effect of astragaloside IV on pyroptosis in human umbilical vein endothelial cells
    Su, Yi; Yin, Xin; Huang, Xin; Guo, Qianqian; Ma, Mingyuan; Guo, Liheng*PHARMACEUTICAL BIOLOGY, 2022, 60(1): 1812-1818.被引 6
  • Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway
    Mo, Yenan; Hu, Dongmei; Yu, Wanlin; Ji, Chunlan; Li, Yin; Liu, Xusheng*; Lu, Zhaoyu*Journal of Ethnopharmacology, 2023, 308: 116244.被引 3
  • Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway
    Su, Yi; Yin, Xin; Huang, Xin; Guo, Qianqian; Ma, Mingyuan; Guo, Liheng*Life Sciences, 2022, 310: 121123.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Human Cell
发表日期
2022-11
卷期
第 35 卷, 第 6 期
页码
1684-1696
DOI
10.1007/s13577-022-00758-6
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81774241, 82174467]

作者

  • L

    Li, Huijun (第一作者)

    1 · guangdong pharmaceut univ

  • X

    Xu, Jialin

    1 · guangdong pharmaceut univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Yanan

    zhejiang univ

  • H

    Hong, Lei

  • H

    He, Zhijian

    1 · guangdong pharmaceut univ

  • Z

    Zeng, Zhiheng (通讯)

    1 · guangdong pharmaceut univ

  • Z

    Zhang, Li (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417